Lymphadenitis - PowerPoint PPT Presentation

1 / 43
About This Presentation
Title:

Lymphadenitis

Description:

Lymphadenitis Doc. MUDr. L. Boudov , Ph.D. Lymphadenitis acute or chronic Classification predominant histologic pattern etiology Lymphadenitis - etiology ... – PowerPoint PPT presentation

Number of Views:2035
Avg rating:3.0/5.0
Slides: 44
Provided by: B297
Category:

less

Transcript and Presenter's Notes

Title: Lymphadenitis


1
Lymphadenitis
  • Doc. MUDr. L. Boudová, Ph.D.

2
Lymphadenitisacute or chronic
Rarely biopsied
  • Classification
  • predominant histologic pattern
  • etiology

3
Lymphadenitis - etiology
  • MICROBIAL
  • viral
  • bacterial, mycobacterial
  • fungal
  • protozoal
  • NONMICROBIAL - autoimmune
  • storage dis.
  • foreign mat.
  • miscel.

4
Lymph node inflammation
  • Lymph node hyperplasia
  • 1. follicular
  • 2. paracortical
  • 3. sinuses
  • 4. mixed patterns

5
Lymph node inflammation
  • Follicular hyperplasia
  • bacteria, RA, HIV(early), syphilis,
  • Castleman dis.
  • Paracortical hyperplasia
  • viruses, dermatopathies, vaccination,
  • drug hypersensitivity, Kikuchi, SLE,
  • draining pus or carcinoma

6
Lymphadenitis - histological patterns
  • sinusoidal hyperplasia - lymphangiography,
    Whipple dis., sin. histiocytosis with massive
    lymphadenopathy, draining carcinoma
  • granulomas - TB, other mycobact., leprosy,
    Whipple, fungi, berylliosis, sarcoidosis,
  • Granulomatous-purulentcat scratch, tularemia,
    lymphogr. venereum,Yersinia
  • mixed patterns toxoplasmosis

7
Red cells
  • Men Women
  • Hemoglobin (g/l) 140-180 120-160
  • Hematocrit () 40-52 36-48
  • Red cell count (1012/l) 4.5-6.5 3.9-5.6
  • Reticulocyte count () 0.5-1.5
  • Mean cell volume (fl) 80-95
  • Mean corpuscular hemoglobin (pg) 27-33
  • Mean corpuscular hemoglobin concentration (gm/dL)
    33-37

8
Red cells
  • pathological conditions
  • decrease in the circulating red cell mass
  • (poss. with structural abnormalities)
  • very common - anaemia
  • II. increase in the circulating red cell mass
  • less common
  • polycythemia erythrocytosispolyglobuly
  • reactive low levels of oxygen in the PB
  • (heart disease, high altitude)
  • neoplastic polycythemia vera
  • chronic myeloproliferative disease

9
Anaemia
  • decrease in the total circulating red cell mass
  • (hematocrit, hemoglobin concentration)
  • Classification A. underlying mechanism
  • blood loss
  • increased destruction
  • decreased production
  • B. morphology of erythrocytes
  • size (micro-, macro-, normocytic)
  • shape (spherocytosis, stomato-,...)
  • color (degree of hemoglobinization normo-
    hypo-, hyperchromic)

10
  • Blood loss
  • acute or chronic
  • internal or external
  • Acute
  • Hypovolemia shock
  • Anemia normocytic normochromic
  • Shift of water hemodilution ? hematocrite
  • Compensatory increase of red cell production
  • Reticulocytes
  • Chronic
  • hypochromic sideropenic anemia

11
Iron deficiency anemia
  • body iron functional storage
  • F - 2g, M - 6g
  • 1. Lack in diet, low absorption
  • 2. Increased requirement
  • !!!3. Chronic blood loss!!! - GIT, GYN

12
  • Increased destruction
  • lysis of red cellshemolysis
  • intravascular rare (mechanical injury
    artificial valves or microthrombi, exogenous
    toxic agents, complement fixation (transfusion of
    mismatched blood)
  • Extravascular - more common, when red cells
    considered foreign or less deformable
  • Hemolytic anemia
  • Abnormality
  • intracorpuscular or extracorpuscular
  • hereditary (intra) or acquired (extra)

13
Hemolytic anemia
  • premature destruction of red cells
  • accumulation of the products of the hemoglobin
    catabolism
  • BM increased erythropoiesis, extreme
    extramedullary hematopoiesis
  • PB reticulocytosis
  • high bilirubin gallstones jaundice, blr in
    urine
  • chronic duration hemosiderosis
  • splenomgaly

14
Myelodysplastic syndrome
  • clonal disorders of stem cells
  • defects of maturation in the BM - ineffective
    hematopoiesis (progressive failure of BM
    function)
  • cells in the PB decreased numbers
    pancytopenia defective in function,
    pathological shapes
  • BM hypercellular,
  • but dysplastic pathological forms, architecture
  • blasts may be increased
  • (but less than 20, threshold AML versus MDS)

15
(Chronic) myeloproliferative neoplasms
  • Clonal disorders
  • Adults
  • 1. Chronic myeloid leukemia
  • 2. Polycythemia vera
  • 3. Essential thrombocytemia
  • 4. Chronic osteomyelofibrosis

16
(Chronic) myeloproliferative neoplasms
  • Common principles
  • 1. Bone marrow stem cell genetic abnormalities,
  • neoplastic proliferation of one or more (all) BM
    myeloid series (red, white, megakaryocytes)
  • disorder of an individual series more pronounced
    in each of the categories
  • 2. Peripheral blood increased numbers of cells
    relatively normal maturation
  • 3. Splenomegaly, hepatomegaly
  • sequestration of excess blood cells,
    extramedullary hematopoiesis, leukaemic
    infiltration

17
Chronic myeloproliferative neoplasms
  • Common principles
  • 1. Bone marrow stem cell genetic abnormalities,
  • neoplastic proliferation of one or more (all) BM
    myeloid series (red, white, megakaryocytes)
  • disorder of an individual series more pronounced
    in each of the categories
  • 2. Peripheral blood increased numbers of cells
    relatively normal maturation
  • 3. Splenomegaly, hepatomegaly
  • sequestration of excess blood cells,
    extramedullary hematopoiesis, leukaemic
    infiltration

18
Chronic myeloproliferative neoplasms
  • phases of the disease in time
  • 1. onset insidious
  • proliferative phase,
  • 2. progression - spent phase -
    osteomyelofibrosis
  • - blast phase
  • all can (do not have to) progress to AL CML does
    it invariably)

19
Chronic myelogenous leukaemia (CML)
  • t(9 22) Philadelphia chromosome, bcr-abl gene
    pluripotent stem cell defect
  • abnormal fusion protein - increased tyrosine
    kinase activity
  • most striking proliferation of G
  • increased cellularity
  • maturation retained (no hiatus leukaemicus)
  • hematopoiesis also extramedullary splenomegaly
    (hepatomegaly)
  • PB leukocytosis exceeds even 100 000/ mm3

20
LymphomasClonal disorders of lymphoid cells at
various stages of differentiation
  • HODGKIN L.
  • NON-HODGKIN L.
  • immature cells (precursors)
  • mature cells
  • B
  • T

Distinction clinical histological
Note Hodgkin lymphoma is also a (mature)B-cell
lymphoma.
21
B-cell lymphoma
  • Clonal disorders of B-cells at various stages
  • of differentiation
  • B-cell lymphomas of immature cells - lymphoblasts
  • B-acute lymphoblastic leukaemia - frequent,
    children
  • B-lymphoblastic lymphoma - rare
  • B-cell lymphomas of mature B-cells
  • most commonfollicular, diffuse large B-cell
    lymphoma plasma cell myeloma

22
Extranodal marginal zone B-cell lymphoma of MALT
  • GIT - stomach
  • lung, head, neck (thyroid, salivary, eyes), skin
  • antigenic stimulation
  • stomach - Helicobacter pylori
  • thyroid - Hashimoto
  • Sjogren
  • IPSID
  • localized - good prognosis
  • RISK transformation - DLBCL

23
Follicular lymphoma
  • Over 60
  • LN, spleen, later BM
  • often asympt.
  • Histology
  • grades
  • transformation - DLBCL

t (1418 bcl2/JHa
24
Diffuse large B-cell lymphoma
  • aggresive, potentially curable
  • COMMON!
  • 1/3 of all lymphomas of adults (med. 64 ys)
  • nodal OR extranodal (1/3)

GIT, skin, CNS, testis bone, soft tissue,
salivary glands, Waldeyer ring, lung, kidney,
liver, spleen, female genital tract
25
Diffuse large B-cell lymphoma
  • Primary OR secondary

Chronic lymphocytic leukemia Follicular
lymphoma Marginal zone B-cell lymphoma Nodular
lymphocyte predom. Hodgkin l.
Risk factor immunodeficiency (often EBV)
26
Diffuse large B-cell lymphoma
  • Morphologic variants
  • Centroblastic
  • Immunoblastic
  • T-cell/histiocyte rich
  • Anaplastic
  • Plasmablastic
  • Clinicopathologic subtypes
  • mediastinal (thymic)
  • intravascular
  • primary effusion, pyothorax associat.

27
Diffuse large B-cell lymphomaDifferential
diagnosis
  • Tumors
  • Haematological lymphomas peripheral - B, T
  • precursors - B, T
  • myeloid neoplasm
  • Non-haematological carcinoma, sarcoma, GIST,
    melanoma, seminoma, glial tumors
  • Reactive disorders infectious mononucleosis,
    Kikuchi

28
Mediastinal DLBCL
  • Thymus
  • Female, 30 ys
  • Anterior mediastinal mass
  • Superior vena cava syndrome
  • Clinicopathological differential diagnosis?

29
Bleeding disorders
30
Bleeding disordersI. Vessels - increased
fragilityII. Platelets - deficiency or
dysfunctionIII.Coagulation disorders
  • I. Vessels
  • infections, drugs (hypersensitivity, poor
    vascular wall Ehlers-Danlos, scurvy Cushing
    syndrome, old people
  • hereditary hemorrhagic teleangiectasia
  • amyloid

31
Thrombocytopenia
  • decreased production
  • increased destruction
  • sequestration
  • dilution
  • HIV

32
Thrombotic microangiopathiesthrombotic
thrombocytopenic purpura (TTP)hemolytic-uremic
syndrome (HUS)
  • Versus
  • Disseminated intravascular coagulation
  • Common hyaline thrombi
  • !!Differences DIC primary importance
  • activation of clotting system

33
Disseminated intravascular coagulation (DIC)
  • secondary complication
  • of some serious condition
  • consumption coagulopathy
  • thrombohemorrhagic diathesis
  • acute, subacute, chronic

34
Disseminated intravascular coagulation (DIC)
  • activation of coagulation sequence
  • microthrombi
  • - consumption of platelets and clotting factors
  • activation of fibrinolysis

secondary
35
DICthrombotic and hemorrhagic diathesis
Consequences
  • Microthrombi infarctions
  • depletion of platelets and clotting factors
  • secondary activation of fibrinolysis

hemorrhages
36
Mechanisms of DIC trigger1. Release of tissue
factor or thromboplastic substances2.
Widespread endothelial injury
37
DIC
  • Morphology microthrombi
  • Kidneys hemorrhages
  • lungs
  • brain
  • adrenals
  • placenta
  • CLIN. microangiopathic hemol. anemia, RDS,
    neurologic sympt., oliguria, ac. ren. and circul.
    failure, SHOCK

38
HODGKIN LYMPHOMA WHO 2008
  • CLASSICAL (95)
  • NODULAR LYMPHOCYTE PREDOMINANT

(nodular paragranuloma, 5)
  • DIFFER IN TUMOUR CELLS
  • BACKGROUND
  • CLINICAL FEATURES

39
CLASSICAL HL
SUBTYPES NODULAR SCLEROSIS MIXED
CELLULARITY LYMPHOCYTE RICH LYMPHOCYTE DEPLETION
  • FEATURES
  • COMMON TUMOUR CELLS
  • DIFFERENT BACKGROUND ARCHITECTURE
  • CLINICAL, EPIDEMIOLOGY
  • EBV

40
Lymphadenitisacute or chronic
Rarely biopsied
  • Classification
  • predominant histologic pattern
  • etiology

41
T-cell lymphoma
  • Precursor T-cell lymphomas
  • T-acute lymphoblastic leukaemia
  • T-lymphoblastic lymphoma
  • Mature T-and NK cell neoplasms
  • uncommon 10 of all NHL
  • Most frequent peripheral T-cell lymphoma,
    unspecified
  • large cell anaplastic lymphoma

42
Most common T-cell lymphomas
  • Leukaemic/disseminated
  • adult T-cell leukaemia - HTLV 1
  • cutaneous - mycosis fungoides, Sezary syndrome,
    primary cut. anaplast. lymphoma
  • other extranodal - extranod. NK/T - nasal,
    enteropathy assoc.
  • nodal - peripheral T-cell lymphoma, NOS,
    anaplastic large cell lymphoma

43
Enteropathy associated T-cell lymphoma
  • coeliac sprue (adults)
  • intestinal perforation
  • intraepithelial
  • T-lymphocytes
  • bad prognosis
Write a Comment
User Comments (0)
About PowerShow.com